Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation

Coronary Artery Disease

Volumn 24, Issue 5, 2013, Pages 368-373

  Yoneda, Shuichi ^a   Abe, Shichiro ^a   Kanaya, Tomoaki ^a   Oda, Kazuhiko ^a   Nishino, Setsu ^a   Kageyama, Michiya ^a   Taguchi, Isao ^a   Masawa, Nobuhide ^a   Inoue, Teruo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

drug eluting stent; in stent restenosis; inflammation; macrophages; wound healing

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CD45 ANTIGEN; CD68 ANTIGEN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PADGEM PROTEIN; TICLOPIDINE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BARE METAL STENT; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIRECTIONAL ATHERECTOMY; DRUG ELUTING STENT; DYSLIPIDEMIA; ENDOTHELIUM CELL; FEMALE; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN-STENT RESTENOSIS; INFLAMMATION; MACROPHAGE; MALE; PARAMETERS; PRIORITY JOURNAL; SMOKING; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; WOUND HEALING;

ACTINS; AGED; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATHERECTOMY, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; METALS; MIDDLE AGED; P-SELECTIN; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RISK FACTORS; T-LYMPHOCYTES; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 84880767392     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32836222ec     Document Type: Article

References (25)

1. Bhatia V, Bhatia R, Dhindsa M. Drug-eluting stents: new era and new concerns. Postgrad Med J 2004; 80:13-18.
2. Costa M, Simon D. Molecular basis of restenosis and drug-eluting stents. Circulation 2005; 111:2257-2273.
3. Lemos PA, van Mieghem CA, Arampatzis CA, Hoye A, Ong AT, McFadden E, et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes. Circulation 2004; 109:2500-2502.
4. Tanaka H, Skhova GK, Swanson SJ, Clinton SK, Ganz P, Cybulsky MI, et al. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993; 88 (Part 1):1788-1803.
5. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002; 22:1769-1776.
6. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005; 112:270-278.
7. Joner M, Finn AV, Mont EK, Kolodgie FD, Ladich E, Kutys R, et al. Pathology of drug-eluting stent in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48:203-205.
8. Webster MW, Ormiston JA. Drug-eluting stents and late stent thrombosis. Lancet 2007; 370:914-915.
9. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48:193-202.
10. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8:403-409.
11. Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009; 73:615-621.
12. Inoue T, Croce K, Morooka T, Sakuma M, Node K, Simon DI. Vascular inflammation and repair: implication for re-endothelialization, restenosis, and stent thrombosis. J Am Coll Cardiol Interv 2011; 4:1057-1066.
13. Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 2007; 115:553-561.
14. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964-966.
15. Gottsauner-Wolf M, Zasmeta G, Hornykewyez S, Nikfardiam M, Stepan E, Wexberg P, et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21:1152-1158.
16. Gaspardone A, Tomai F, Versaci F, Ghini AS, Polisca P, Chiariello L, et al. Coronary artery stent placement in patients with variant angina refractory to medical treatment. Am J Cardiol 1999; 84:96-98.
17. Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I, et al. Immunosuppressive therapy for the prevention of restenosis after coronary stent implantation (IMPRESS Study). J Am Coll Cardiol 2002; 40:1935-1942.
18. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996; 28:1127-1133.
19. Inoue T, Sakai Y, Hoshi K, Yaguchi I, Fujito T, Morooka S. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation 1998; 97:2511-2518.
20. Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S. Activation process of platelets and neutrophils after coronary stent implantation: comparison with balloon angioplasty. Am J Cardiol 2000; 86:1057-1062.
21. Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, Morooka S. Stentinduced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 2003; 107:1757-1763.
22. Shiode N, Shirota Y, Katou Y, Tsunoda F, Fujiwara M, Miura M. Late progression after sirolimus-eluting stent implantation: comparison with bare metal stent implantation. J Am Coll Cardiol 2009; 53 (Suppl):A12.
23. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109: 701-705.
24. Byrne RA, Joner M, Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol 2009; 57:567-584.
25. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27:1500-1510. Sports, Science and Technology of Japan